Quick Answer
Bio Essence Corp reported Operating Income Loss of $900.0 thousand for the year ending 2025.
- Bio Essence Corp showed an increase of +295.9% in Operating Income Loss from 2024 to 2025.
- This data is from Bio Essence Corp's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$120.3 thousand | Q2 2020: -$196.3 thousand | Q3 2020: -$187.1 thousand | Q1 2021: -$204.5 thousand | Q2 2021: -$261.3 thousand | Q3 2021: -$192.9 thousand | Q1 2022: -$226.4 thousand | Q2 2022: -$155.9 thousand | Q3 2022: -$192.6 thousand | Q1 2023: -$24.3 thousand | Q2 2023: -$226.7 thousand | Q3 2023: -$82.6 thousand | Q1 2024: -$151.8 thousand | Q2 2024: -$165.0 thousand | Q3 2024: -$146.4 thousand | Q1 2025: -$205.1 thousand | Q2 2025: $61.2 thousand | Q3 2025: $14.3 thousand.
- Over the full 6 years of available data (2020 to 2025), Bio Essence Corp's Operating Income Loss has grown by 208.1%.
- Historical annual values: Fiscal year 2025: $900.0 thousand | Fiscal year 2024: -$459.4 thousand | Fiscal year 2023: -$345.6 thousand | Fiscal year 2022: -$511.1 thousand | Fiscal year 2021: -$857.5 thousand | Fiscal year 2020: -$832.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: